ArticlePolymers2026
PLA/Collagen/Hydroxyapatite Ternary Biocomposites for Biodegradable Bone Screw Applications.
Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Poly(lactic acid) (PLA)-based biocomposites incorporating collagen (COLL) and hydroxyapatite (HA) were produced via melt micro-compounding and subsequent injection molding. 1,4-phenylene diisocyanate (PDI) was employed as a compatibilizer, while poly(ethylene glycol) (PEG) was used as a plasticizer. The morphological, thermal, rheological, and mechanical properties, as well as surface wettability, degradation behavior, and cytotoxicity, were comprehensively evaluated. SEM and DSC analyses revealed the phase distribution and thermal transitions, while rheological measurements showed that PEG reduced melt viscosity by increasing chain mobility. Mechanical performance was evaluated using tensile, impact, and DMA tests on standard specimens, indicating that HA primarily enhanced stiffness (elastic modulus), whereas PEG improved toughness, resulting in higher impact strength. Biodegradable bone screw prototypes were produced with the same formulations and subjected to torsion, enzymatic degradation, and MTT cytotoxicity tests. Degradation results indicated that biocomposites containing PEG, collagen, and HA exhibited accelerated mass loss. Overall, the 70/20/10 PLA/COLL/HA/PEG/PDI formulation was more suitable for soft (trabecular) bone tissue, while the 70/10/20 PLA/COLL/HA/PDI formulation showed advantages for hard (cortical) bone tissue applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.